- Home
- RUN vs VKTX Comparison
RUN vs VKTX Comparison
Compare RUN & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RUN
- VKTX
- Stock Information
- Founded
- RUN 2007
- VKTX 2012
- Country
- RUN United States
- VKTX United States
- Employees
- RUN N/A
- VKTX N/A
- Industry
- RUN Industrial Machinery/Components
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- RUN Miscellaneous
- VKTX Health Care
- Exchange
- RUN Nasdaq
- VKTX Nasdaq
- Market Cap
- RUN 2.8B
- VKTX 2.8B
- IPO Year
- RUN 2015
- VKTX 2015
- Fundamental
- Price
- RUN $9.47
- VKTX $26.64
- Analyst Decision
- RUN Buy
- VKTX Buy
- Analyst Count
- RUN 21
- VKTX 12
- Target Price
- RUN $15.01
- VKTX $84.00
- AVG Volume (30 Days)
- RUN 24.6M
- VKTX 2.9M
- Earning Date
- RUN 08-05-2025
- VKTX 07-23-2025
- Dividend Yield
- RUN N/A
- VKTX N/A
- EPS Growth
- RUN N/A
- VKTX N/A
- EPS
- RUN N/A
- VKTX N/A
- Revenue
- RUN $2,083,802,000.00
- VKTX N/A
- Revenue This Year
- RUN $11.10
- VKTX N/A
- Revenue Next Year
- RUN $11.66
- VKTX N/A
- P/E Ratio
- RUN N/A
- VKTX N/A
- Revenue Growth
- RUN N/A
- VKTX N/A
- 52 Week Low
- RUN $5.45
- VKTX $18.92
- 52 Week High
- RUN $22.26
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- RUN 57.60
- VKTX 47.02
- Support Level
- RUN $8.12
- VKTX $25.61
- Resistance Level
- RUN $10.14
- VKTX $30.17
- Average True Range (ATR)
- RUN 0.76
- VKTX 1.45
- MACD
- RUN 0.14
- VKTX -0.09
- Stochastic Oscillator
- RUN 87.69
- VKTX 24.44
About RUN Sunrun Inc.
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed either by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.